With the total monkeypox cases in the U.S. hitting 16,000, the White House is looking to create greater accessibility for the monkeypox vaccine.

The White House response team says they are in phase four of their current vaccine strategy, and officials say that they have shipped an additional 188,000 additional vaccine vials - which is 940,000 more doses.

The White House has allocated 1.1 million vials of the Jynneos vaccine and shipped half of those to thw FDA authorizing the treatment for emergency use.

"By the end of phase 4 we would have provided enough viles to states and jurisdictions to provide more than 3 million doses of  vaccines," said Dawn O'Connell, assistant director for preparedness and response. "Meaning we have provided nearly enough vaccines to reach the at risk population."

While much progress has been made, health officials say that as of Monday 48,000 vials have been shipped to states that have been able to prove that 85% of their supply has been used.

Ashwin Vassan, commissioner of the city's health department, provided the following statement regarding a case of a juvenile contracting monkeypox:

“There is a juvenile case of MPV (or monkeypox) in New York City. While we understand the concerns of families, we also know that the overall risk of exposure for children in the city remains very low.